OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor
Peng Qiu, Lujuan Wang, Liang Zuo, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 1, pp. 9-17
Closed Access | Times Cited: 22

Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid/ER stress axis-induced blockade of autophagy
Zeyuan Yin, Shi-min He, Xinyuan Zhang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access

Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights
Xinyu Li, Haiying Zhao
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access

Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma
Guanjie Ji, Yue Li, Zhiyue Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24667-e24667
Open Access | Times Cited: 4

Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 4

Anti-tumor effect and mechanism of the total biflavonoid extract from S doederleinii on human cervical cancer cells in vitro and in vivo
Shilan Lin, Zhijie Chen, Shaoguang Li, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24778-e24778
Open Access | Times Cited: 3

Research progress on natural products against hepatocellular carcinoma
LINGLI ZHANG, Yan Li, Jingxin Mao
Biocell (2024) Vol. 48, Iss. 6, pp. 905-922
Open Access | Times Cited: 3

Advances in experimental animal models of hepatocellular carcinoma
Jing Li, Xin Wang, Mudan Ren, et al.
Cancer Medicine (2023) Vol. 12, Iss. 14, pp. 15261-15276
Open Access | Times Cited: 8

MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy
Xianjun Yu, Mengyuan Feng, Jian Guo, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 8, pp. 1085-1098
Closed Access | Times Cited: 2

MR-Based Radiomics Predicts CDK6 Expression and Prognostic Value in High-grade Glioma
Chen Sun, Chenggang Jiang, X. L. Wang, et al.
Academic Radiology (2024) Vol. 31, Iss. 12, pp. 5141-5153
Open Access | Times Cited: 2

Exogenous H2S alleviates senescence of glomerular mesangial cells through up-regulating mitophagy by activation of AMPK-ULK1-PINK1-parkin pathway in mice
E Ya‐Qi, Yan Lin, Guoliang Yan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 8, pp. 119568-119568
Closed Access | Times Cited: 5

Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1
Prudencio Sáez-Martínez, Francisco Porcel-Pastrana, Antonio J. Montero‐Hidalgo, et al.
Cancer Letters (2024) Vol. 584, pp. 216604-216604
Open Access | Times Cited: 1

The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma
Aoming Cheng, Qiaoshi Xu, Bo Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 1

Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy
Guanjun Chen, Ganghua Zhang, Yuxing Zhu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Ubenimex suppresses glycolysis mediated by CD13/Hedgehog signaling to enhance the effect of cisplatin in liver cancer
YunYan Shi, Qie Guo, Fanjing Jing, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 10, pp. 2823-2836
Open Access | Times Cited: 2

Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review)
Wenyue Gao, Jing Wang, Yuting Xu, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 1
Open Access

Will AMPK be a potential therapeutic target for hepatocellular carcinoma?
Guo Chen, Mingyuan Li, Jingyi Yang, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3241-3258
Open Access

Activating transcription factor 4 plays a major role in shaping the transcriptional response to isoginkgetin in HCT116 cells
Erin J. Vanzyl, John D. H. Stead, Claire Peneycad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat‐Moghadam, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access

SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis
Ganggang Wang, Wenzhi Jin, Lianmei Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access

Cross‐talk of pyroptosis‐based subtypes, the development of a risk classifier and immune responses in cervical cancer
Jiamin Gu, Bo Ding
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access | Times Cited: 1

Page 1

Scroll to top